Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-17-000934
Filing Date
2017-01-30
Accepted
2017-01-30 17:00:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 593138
2 image_001.jpg GRAPHIC 9299
  Complete submission text file 0001493152-17-000934.txt   607263
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-215672 | Film No.: 17558223
SIC: 2834 Pharmaceutical Preparations